Top Story

Infant mortality, morbidity similar for ampicillin-susceptible, ampicillin-resistant E. coli

July 2, 2015

Data from a recent study showed there were no clinically relevant differences in mortality and morbidity among infant patients diagnosed with blood stream infections caused by either ampicillin-susceptible or ampicillin-resistant Escherichia coli.

Researcher Stephen P. Bergin, MD, of Duke University School of Medicine, and colleagues compiled a cohort of 258 infant patients discharged from one of 77 U.S. neonatal ICUs. Ampicillin resistance was identified in 48% of the infants with E. coli bloodstream infections; the remainder were infected with ampicillin-susceptible E. coli.

Meeting News Coverage

Cuba first country to eliminate vertical transmission of HIV, syphilis

July 1, 2015
WHO has recognized Cuba as the first country to officially meet all requirements for elimination of mother-to-child transmission of HIV and syphilis.To receive…
VIDEO: Cure is ‘next frontier’ of HIV At IssueVideo

VIDEO: Cure is ‘next frontier’ of HIV

July 1, 2015
Timothy Brown – the Berlin patient – has led researchers to the next frontier of HIV research, according to Janice E. Clements, PhD, molecular virologist…

Hospitals that use reusable sharps containers have higher rates of C. difficile infection

July 1, 2015
A new study showed acute care hospitals that use reusable sharps containers have higher rates of Clostridium difficile infection, according to a press release. These…
Study shows Medicaid restrictions for Sovaldi create barriers for care In the Journals

Study shows Medicaid restrictions for Sovaldi create barriers for care

July 1, 2015
In a new study published in Annals of Internal Medicine, researchers found that Medicaid coverage restrictions for Sovaldi may not be allowing certain patients with…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
At Issue Video
VIDEO: James A. Hoxie, MD, discusses intense energy of emerging HIV cure research

VIDEO: James A. Hoxie, MD, discusses intense energy of emerging HIV cure research

July 1, 2015
The “intense” energy felt by scientists working on HIV research comes from the relatively recent idea that…
More »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
morganatic-roan